arrow
R

Robert J. Lewandowski

northwestern university
H指数:75
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II Single-Arm Study of Durvalumab and Bevacizumab Following Transarterial Radioembolisation in Unresectable Hepatocellular Carcinoma (EMERALD-Y90): Interim Safety Analysis with Contextualisation Using an External Comparator Arm

不可切除肝细胞癌经动脉放射性栓塞术后 durvalumab 和 bevacizumab 的单臂 II 期研究(EMERALD-Y90):使用外部对照臂进行背景化的中期安全性分析

Cancers
IF4.4
2026-11-130
OA
Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients

基线血红蛋白预测接受钇-90放射性栓塞治疗的肝内胆管癌患者的肿瘤学结局:一项136例患者的回顾性队列研究

2026-08-011
PRE
Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia

基线高胆红素血症患者节段性放射性栓塞治疗肝细胞癌的成功搭桥或降期率及安全性

2026-04-020
PRE
Safety and feasibility of Y90 radioembolization for cirrhosis-induced splenomegaly and thrombocytopenia: results from an investigational device exemption study

Y90放射性栓塞术治疗肝硬化所致脾肿大和血小板减少的安全性与可行性:一项 investigational device exemption 研究的结果

2026-02-140
PRE
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment (NOV, 10.1148/radiol.232408, 2024)

CT/MRI LI-RADS 2024年更新:治疗反应评估(NOV, 10.1148/radiol.232408, 2024)

RADIOLOGY
IF15.2
2025-02-010
PRE
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment
RADIOLOGY
IF15.2
2024-11-010
PRE